Showing results (121-130 of 321) with videos related to
Sort By:
Pageof 33
Journal of the American Geriatrics Society|June 1, 1993
Functional decline in Alzheimer's disease: a longitudinal studyC R Green, R C Mohs, J Schmeidler, et al.Endocrinology and Metabolism Clinics of North America|March 1, 1988
Endocrine changes in Alzheimer's diseaseM Davidson, L Bastiaens, B M Davis, et al.Biological Psychiatry|June 15, 1994
Clozapine treatment and its effect on neuroendocrine responses induced by the serotonin agonist, m-chlorophenylpiperazineR S Kahn, M Davidson, L J Siever, et al.Biological Psychiatry|October 6, 1999
Cognitive and functional changes with aging in schizophreniaJ I Friedman, P D Harvey, E Kemether, et al.Blood|May 11, 1999
Regulated expression and functional role of the transcription factor CHOP (GADD153) in erythroid growth and differentiationM Coutts, K Cui, K L Davis, et al.Proceedings of the National Academy of Sciences of the United States of America|March 14, 1998
Human erythropoietin dimers with markedly enhanced in vivo activityA J Sytkowski, E D Lunn, K L Davis, et al.Experimental Hematology|November 1, 1993
Antipeptide antibodies as probes of the recombinant and endogenous murine erythropoietin receptorsS C Bailey, L Feldman, R R Romanowski, et al.Glia|July 25, 2014
Myelination, oligodendrocytes, and serious mental illnessV Haroutunian, P Katsel, P Roussos, et al.The American Journal of Psychiatry|December 1, 1994
Early response to clozapine in schizophreniaR G Stern, R S Kahn, M Davidson, et al.The American Journal of Psychiatry|November 1, 1994
Clinical symptoms associated with age at onset in Alzheimer's diseaseB A Lawlor, T M Ryan, J Schmeidler, et al.Pageof 33